Dr. Alan Tan is an assistant professor in the Division of Hematology, Oncology and Cell Therapy at Rush Medical College. As the Director of GU Medical vz Oncology, Dr. Tan is dedicated to improving the lives of patients with genitourinary tumors. He specializes in kidney cancer, bladder cancer, prostate cancer and melanoma. He also has an extensive background in hematologic malignancies.

Dr. Tan has clinical research interest in designing and implementing clinical trials to test novel immunotherapies and targeted therapies for melanoma, renal cell carcinoma, prostate cancer and urothelial malignancies. He also has interest and expertise in precision genomic cancer medicine, identifying molecular alterations that will serve as targets for individualized treatment
strategies. Dr. Tan serves as executive officer for the GU section of Alliance for Clinical Trials

Education:
St. Georges University School of Medicine

Current Position(s)

• Assistant Professor, Rush University – Chicago, Illinois
• Director of Genitourinary Malignancies
• Executive Officer — Alliance for Clinical Trials

Additional information:

• Member of the American Society of Oncology, Society for Inmunotherapy of Cancer, and American Society of Hematology.
• Former Director of clinical research and hematology at Cancer Treatment Centers of America